Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms

Neuroscience Letters
Shusuke NumataTetsuro Ohmori

Abstract

Brain-derived neurotrophic factor (BDNF) is a neurotrophic factor that promotes several functions of neurons and modulates neurotransmissions. It has been reported that there are alterations of BDNF levels in schizophrenic brains and that BDNF gene expressional changes would be responsible for the etiology of schizophrenia. Recent studies have shown that a variation of BDNF gene (Val66Met polymorphism) affects the function of neurons, and is associated with several neurological and psychiatrical disorders. We investigated the relationship between BDNF Val66Met polymorphism and the onset age as well as levels of clinical symptoms in 159 of chronic schizophrenia in-patients diagnosed by DSM-IV. The mean onset ages were 27.5+/-9.5 for BDNF Val/Val, 25.5+/-7.4 for BDNF Val/Met and 22.9+/-6.0 for BDNF Met/Met and this polymorphism was significantly associated with age at onset (P=0.023). The mean Brief Psychiatric Rating Scale scores (BPRS) were significantly different among those three groups (P=0.003). No significant differences were demonstrated comparing the BDNF genotype distributions of positive and negative family history (P=0.21). Our investigation indicates that the BDNF gene Val66Met polymorphism is related to the onset ag...Continue Reading

References

Jun 1, 1996·The Keio Journal of Medicine·T Inada, G Yagi
Jan 1, 1995·Schizophrenia Bulletin·R W Buchanan
Oct 12, 2001·Schizophrenia Research·N DuranyJ Thome
Nov 13, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lukas PezawasDaniel R Weinberger
Jan 4, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Araceli RosaLourdes Fañanás

❮ Previous
Next ❯

Citations

Mar 12, 2008·Annals of Biomedical Engineering·Andreas WindemuthGualberto Ruaño
Jan 28, 2010·Psychological Medicine·M ShaikhE Bramon
Mar 13, 2012·Pharmacological Reviews·Anita E Autry, Lisa M Monteggia
Oct 17, 2013·Journal of Neuropathology and Experimental Neurology·Ludmyla KandrataviciusJoao Pereira Leite
May 10, 2015·Neuroscience and Biobehavioral Reviews·F HarrisbergerS Borgwardt
Nov 26, 2015·Schizophrenia Research·Xiang Yang ZhangJair C Soares
Apr 28, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Dong Hao ZhouXiang Yang Zhang
May 2, 2009·Schizophrenia Research·Kunihiro KawashimaNakao Iwata
Mar 31, 2009·Schizophrenia Research·Tomo OkochiNakao Iwata
Dec 9, 2008·Comprehensive Psychiatry·Dost OngürBruce M Cohen
May 13, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Tsutomu TakahashiNorio Ozaki
Apr 24, 2008·The European Journal of Neuroscience·Yong-Jun FanXin-Fu Zhou
Feb 10, 2011·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Jeroen DecosterRuud van Winkel
Jul 9, 2013·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Wenjun LiXiang Yang Zhang
Oct 20, 2010·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Heather C WhalleyStephen M Lawrie
Apr 8, 2009·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Elizabeth HareMichael A Escamilla
Sep 12, 2009·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Maria VaresErik G Jönsson
Sep 12, 2006·Neurobiology of Disease·Shotaro KishikawaJames F Gusella
Dec 7, 2010·Progress in Neurobiology·Christin Glorioso, Etienne Sibille
May 25, 2010·Psychiatry Research·Meghana S KarnikJohn G Csernansky
Jan 24, 2015·The International Journal of Neuropsychopharmacology·Wolfgang StrubeAlkomiet Hasan
Sep 20, 2011·Brain Research Bulletin·Chen-Jee HongShih-Jen Tsai
May 1, 2012·Neuroscience Letters·Vanessa Faria GonçalvesJames L Kennedy
Feb 23, 2013·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Hye Ji MinDuk-In Jon
Nov 4, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Nela PivacDorotea Muck Seler
Jan 7, 2015·Neuroscience and Biobehavioral Reviews·Michael NotarasMaarten van den Buuse
Aug 5, 2016·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Sung-Wan KimJin-Sang Yoon
Jun 25, 2017·Neuroscience and Biobehavioral Reviews·Angela IannitelliGiuseppe Bersani
May 19, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Jun-ichi IgaTetsuro Ohmori
Sep 27, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Helen M ChaoBarbara Porton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here